Pfizer is sinking billions in profits from COVID-19 into developing and marketing potential new treatment blockbusters for conditions like migraines, sickle cell disease and obesity.
Nov 8, 2022
Image
A COLOGUARD COLORECTAL SCREENING TEST PACKAGE, READY FOR RETURN TO EXACT SCIENCES/WIKIMEDIA CREATIVE COMMONS/GNESENER1900
The rollout would begin the week of Sept. 20 for U.S. residents 18 and older who received their second shot of the Moderna or Pfizer-BioNTech vaccines at least eight months previously.
A Pfizer win in a lawsuit against the federal government could cost taxpayers billions of dollars and erase an important control on pharma marketing after decades of regulatory erosion and soaring drug prices, say health policy analysts.
Booster shots are likely to be here before long because of the outdated, 60-year-old basic standard the Food and Drug Administration uses to authorize medicines for sale.
The Centers for Disease Control and Prevention is set to meet on Friday to discuss whether rare instances of a heart disorder merit changing its recommendations for vaccinating teenagers with the Pfizer vaccine.
Jun 17, 2021
Image
OHSU receiving a shipment of Pfizer BioNTEch COVID-19 vaccine.
|
OHSU/FRITZ LIEDTKE